Mucormycosis and Role of COVID-19 in its Pathogenicity in India: A Review
DOI:
https://doi.org/10.21276/apjhs.2022.4S1.26Keywords:
Clinical microbiology, Environmental microbiology, Immunology, Infectious disease, MucormycosisAbstract
Mucormycosis is a rising cause of invasive fungal infection but difficulty in diagnosis is the biggest detriment to early diagnosis. Rhinocerebral zygomycosis is most prevalent leading to vascular invasion, tissue necrosis, or even death. Rhizopus arrhizus is the most common causative agent of the disease, found on decaying organic matter but disease from Cunninghamella and Rhizomucor species should not be overlooked. The recent outbreak of COVID-19 pandemic has given rise to increasing patients of diabetes mellitus whose post-COVID immunocompromised state coupled with steroid use has led to rising numbers of mucormycosis patients in India. The establishment of a standard for permissible levels of microbial load in indoor environments has been suggested.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Chiradeep Basu, Subarna Bhattacharyya
This work is licensed under a Creative Commons Attribution 4.0 International License.
Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.
